Trump’s HHS pick unlikely to crack down on drug prices

Alex Azar, nominee to run HHS, worked at Eli Lilly for almost 10 years. Photo: Darron Cummings / AP

President Trump has said drug companies are "getting away with murder" and vowed to bring down their prices. But Alex Azar, his pick to lead the Health and Human Services Department, is a 10-year veteran of pharma giant Eli Lilly, and has endorsed the same free-market philosophy as other conservative business leaders.

The bottom line: There's no indication in Azar's words or deeds that he's likely to pursue large-scale pricing reforms.